Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ARGAN INC
Report date September 12, 2025 · Filed September 15, 2025
Section 16 reporting ended · disclosed 2025-09-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,802 |
Reported balance
Holding disclosure · report date 2025-09-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,802 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $50.30 · Expires 2029-04-12 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2025-09-12 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 10,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $54.60 · Expires 2031-04-16 | Direct | 3,500 |
Reported balance
Holding disclosure · report date 2025-09-12 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 3,500 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $39.47 · Expires 2033-04-17 | Direct | 2,500 |
Reported balance
Holding disclosure · report date 2025-09-12 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 2,500 |
| Time-Based Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,166 |
Reported balance
Holding disclosure · report date 2025-09-12 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 4,166 F1: Pursuant to the vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on September 13, 2022, 4,166 shares of Common Stock will became issuable to the Reporting Person on September 13, 2025 and will be adjusted for dividends. |
| Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,500 |
Reported balance
Holding disclosure · report date 2025-09-12 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 2,500 F2: On September 13, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 2,500 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 2,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. |
| Earnings Per Share Performance-Based Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,500 |
Reported balance
Holding disclosure · report date 2025-09-12 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 2,500 F3: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each EPSRSU represents a contingent right to achieve one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on September 13, 2022, 4,166 shares of Common Stock will became issuable to the Reporting Person on September 13, 2025 and will be adjusted for dividends.
F2: On September 13, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 2,500 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 2,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.
F3: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each EPSRSU represents a contingent right to achieve one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2025 Filed Jul 31, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 1,604 | $242.77 | $389,403.08 |
DisclosureSEC source: 0001415889-25-020720 · form4-07312025_040703.xml · nonDerivative · entry 2 Deily Richard H · CIK 0001358787 · Compliance Officer, Former CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,802 F2 · shares: On July 31, 2025, the Reporting Person sold 1,604 shares of the Issuer's common stock on the open market at an average price of $242.77 per share. Read SEC document |
| July 30, 2025 Filed Jul 31, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,500 | $36.78 Strike: $36.78 | $128,730.00 |
DisclosureSEC source: 0001415889-25-020720 · form4-07312025_040703.xml · derivative · entry 3 Deily Richard H · CIK 0001358787 · Compliance Officer, Former CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 1,500 shares Expires 2032-04-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On July 30, 2025, the Reporting Person exercised his stock option awarded on April 18, 2022 to purchase 3,500 shares of the Issuer's common stock at a price of $36.78 per share, using the net settle method. Read SEC document |
| July 30, 2025 Filed Jul 31, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,604 | $36.78 | $58,995.12 |
DisclosureSEC source: 0001415889-25-020720 · form4-07312025_040703.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · Compliance Officer, Former CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On July 30, 2025, the Reporting Person exercised his stock option awarded on April 18, 2022 to purchase 3,500 shares of the Issuer's common stock at a price of $36.78 per share, using the net settle method. Read SEC document |
| April 30, 2025 Filed May 1, 2025 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 1,565 | $152.32 | $238,380.80 |
DisclosureSEC source: 0001415889-25-011647 · form4-05012025_040502.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · Compliance Officer, Former CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,802 F1 · shares: On April 30, 2025, the Reporting Person sold 1,565 shares of the Issuer's common stock on the open market at a price of $152.32 per share. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 21:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,000 | $150.00 | $300,000.00 |
DisclosureSEC source: 0001415889-25-001261 · form4-01102025_040101.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · Compliance Officer, Former CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,367 F1 · shares: On January 8, 2025, the Reporting Person sold 2,000 shares of the Issuer's common stock on the open market at a price of $150 per share. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 4,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023435 · form4-09162024_040901.xml · derivative · entry 2 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,334 Underlying: Common Stock · 4,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on September 13, 2022, 4,167 shares of Common Stock became issuable to the Reporting Person on September 13, 2024. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on September 13, 2022, 4,167 shares of Common Stock became issuable to the Reporting Person on September 13, 2024. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023435 · form4-09162024_040901.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on September 13, 2022, 4,167 shares of Common Stock became issuable to the Reporting Person on September 13, 2024. Read SEC document |
| June 14, 2024 Filed Jun 17, 2024 20:05 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $64.25 | $0.00 |
DisclosureSEC source: 0001415889-24-017145 · form4-06172024_040612.xml · derivative · entry 2 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500 Underlying: Common Stock · 10,000 shares Expires 2027-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 14, 2024, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's Common Stock at a price of $64.25 per share, using the net settle method. Read SEC document |
| June 14, 2024 Filed Jun 17, 2024 20:05 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 815 | $64.25 | $52,363.75 |
DisclosureSEC source: 0001415889-24-017145 · form4-06172024_040612.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 14, 2024, the Reporting Person exercised his stock option to purchase 10,000 shares of the Issuer's Common Stock at a price of $64.25 per share, using the net settle method. Read SEC document |
| April 19, 2024 Filed Apr 19, 2024 20:15 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 6,256 | $61.15 | $382,554.40 |
DisclosureSEC source: 0001415889-24-011215 · form4-04192024_040402.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,185 F1 · shares: On April 19, 2024, the Reporting Person sold 6,256 shares of the Issuer's Common Stock on the open market at an average price of $61.15 per share. Read SEC document |
| April 18, 2024 Filed Apr 18, 2024 21:42 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-011143 · form4-04182024_090410.xml · derivative · entry 10 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,501 Underlying: Common Stock · 1,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 18, 2022, 1,167 shares of Common Stock became issuable to the Reporting Person on April 18, 2024. F5 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 18, 2022, 1,167 shares of Common Stock became issuable to the Reporting Person on April 18, 2024. Read SEC document |
| April 18, 2024 Filed Apr 18, 2024 21:42 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-011143 · form4-04182024_090410.xml · nonDerivative · entry 5 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 18, 2022, 1,167 shares of Common Stock became issuable to the Reporting Person on April 18, 2024. Read SEC document |
| April 16, 2024 Filed Apr 18, 2024 21:42 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $33.81 | $0.00 |
DisclosureSEC source: 0001415889-24-011143 · form4-04182024_090410.xml · derivative · entry 9 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,500 Underlying: Common Stock · 10,000 shares Expires 2031-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On April 16, 2024, the Reporting Person exercised his stock option awarded on April 16, 2021 to purchase 10,000 shares of the Issuer's Common Stock at a price of $33.81 per share. Read SEC document |
| April 16, 2024 Filed Apr 18, 2024 21:42 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $37.60 | $0.00 |
DisclosureSEC source: 0001415889-24-011143 · form4-04182024_090410.xml · derivative · entry 8 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,500 Underlying: Common Stock · 10,000 shares Expires 2028-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On April 16, 2024, the Reporting Person exercised his stock option awarded on April 13, 2018 to purchase 10,000 shares of the Issuer's Common Stock at a price of $37.60 per share. Read SEC document |
| April 16, 2024 Filed Apr 18, 2024 21:42 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $33.85 | $0.00 |
DisclosureSEC source: 0001415889-24-011143 · form4-04182024_090410.xml · derivative · entry 7 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,500 Underlying: Common Stock · 10,000 shares Expires 2026-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On April 16, 2024, the Reporting Person exercised his stock option awarded on April 13, 2016 to purchase 10,000 shares of the Issuer's Common Stock at a price of $33.85 per share. Read SEC document |
| April 16, 2024 Filed Apr 18, 2024 21:42 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,166 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-011143 · form4-04182024_090410.xml · derivative · entry 6 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,668 Underlying: Common Stock · 1,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2021, 1,166 shares of Common Stock became issuable to the Reporting Person on April 16, 2024. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2021, 1,166 shares of Common Stock became issuable to the Reporting Person on April 16, 2024. Read SEC document |
| April 16, 2024 Filed Apr 18, 2024 21:42 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,192 | $33.81 | $74,111.52 |
DisclosureSEC source: 0001415889-24-011143 · form4-04182024_090410.xml · nonDerivative · entry 4 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On April 16, 2024, the Reporting Person exercised his stock option awarded on April 16, 2021 to purchase 10,000 shares of the Issuer's Common Stock at a price of $33.81 per share. Read SEC document |
| April 16, 2024 Filed Apr 18, 2024 21:42 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,875 | $37.60 | $70,500.00 |
DisclosureSEC source: 0001415889-24-011143 · form4-04182024_090410.xml · nonDerivative · entry 3 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: On April 16, 2024, the Reporting Person exercised his stock option awarded on April 13, 2018 to purchase 10,000 shares of the Issuer's Common Stock at a price of $37.60 per share. Read SEC document |
| April 16, 2024 Filed Apr 18, 2024 21:42 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,189 | $33.85 | $74,097.65 |
DisclosureSEC source: 0001415889-24-011143 · form4-04182024_090410.xml · nonDerivative · entry 2 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On April 16, 2024, the Reporting Person exercised his stock option awarded on April 13, 2016 to purchase 10,000 shares of the Issuer's Common Stock at a price of $33.85 per share. Read SEC document |
| April 16, 2024 Filed Apr 18, 2024 21:42 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 681 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-011143 · form4-04182024_090410.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2021, 1,166 shares of Common Stock became issuable to the Reporting Person on April 16, 2024. Read SEC document |
| September 13, 2023 Filed Sep 28, 2023 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 4,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-013627 · form4-09282023_040901.xml · derivative · entry 2 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,834 Underlying: Common Stock · 0 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit awarded to the Reporting Person on September 13, 2022, 4,167 shares of Common Stock became issuable to the Reporting Person on September 13, 2023. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit awarded to the Reporting Person on September 13, 2022, 4,167 shares of Common Stock became issuable to the Reporting Person on September 13, 2023. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit awarded to the Reporting Person on September 13, 2022, 4,167 shares of Common Stock became issuable to the Reporting Person on September 13, 2023. Read SEC document |
| September 13, 2023 Filed Sep 28, 2023 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-013627 · form4-09282023_040901.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,198 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-006710 · form4-04192023_040407.xml · derivative · entry 6 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,001 Underlying: Common Stock · 1,198 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 1,198 shares of Common Stock. This issuance is pursuant to the ratable three-year vesting schedule of the 3,500 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends. F2 · derivative.expiration_date: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 1,198 shares of Common Stock. This issuance is pursuant to the ratable three-year vesting schedule of the 3,500 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends. F7 · balance_after: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 1,167 shares of TBRSUs granted on April 16, 2021; (b) 2,334 shares of TBRSUs granted on April 18, 2022; and (c) 12,500 shares of TBRSUs granted on September 13, 2022; all to vest pursuant to their respective three-year vesting schedule. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-006710 · form4-04192023_040407.xml · nonDerivative · entry 2 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On April 18, 2023, the Reporting Person had TBRSUs vest in the amount of 1,198 shares of Common Stock. This issuance is pursuant to the ratable three-year vesting schedule of the 3,500 TBRSU award that was granted on April 18, 2022 and is adjusted for cash dividends. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantEarnings Per Share Performance-Based Restricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-006710 · form4-04192023_040407.xml · derivative · entry 5 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F6 · derivative.exercise_date: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievenent of the EPS ranking at the end of the three-year performance period. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each EPSRSU represents a contingent right to achieve one share of the Issuer's common stock. F6 · derivative.expiration_date: On April 17, 2023, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 2,500 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2024, 2025 and 2026 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2021, 2022 and 2023. The pay-out ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievenent of the EPS ranking at the end of the three-year performance period. The awards will be more fully described in the Issuer's 2023 Proxy Statement. Each EPSRSU represents a contingent right to achieve one share of the Issuer's common stock. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $39.47 | $0.00 |
DisclosureSEC source: 0001415889-23-006710 · form4-04192023_040407.xml · derivative · entry 4 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,500 Underlying: Common Stock · 2,500 shares Expires 2033-04-17 F3 · shares: On April 17, 2023, the Reporting Person received 10-year options to purchase 2,500 shares of the Issuer's common stock with an exercise price of $39.47 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 4/17/2024. F4 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options acquire 10,000 shares of common stock at the price of $33.85 per share with a Date Exercisable of 04/13/2017 and Expiration Date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029; F5 · balance_after: (e) options to acquire 10,000 shares of common stock at a price of $33.81 per share with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030; (f) options to acquire 3,500 shares of common stock at a price of $54.60 per share with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031; (g) options to acquire 3,500 shares of common stock at a price of $36.78 per share with a Date Exercisable of 4/18/2023 and Expiration Date of 4/18/2032; and (h) options to acquire 2,500 shares of common stock at a price of $39.47 with a Date Exercisable of 4/17/2024 and Expiration Date of 4/17/2033. Options identified in subjects (c), (d), (e), (f), (g) and (h) are subject to the three-year ratable vesting schedule described in Footnote 3. Read SEC document |
| April 16, 2023 Filed Apr 19, 2023 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,227 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-006710 · form4-04192023_040407.xml · derivative · entry 3 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,167 Underlying: Common Stock · 1,227 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 1,227 shares of Common Stock. This issuance is pursuant to the ratable three year vesting schedule of the 3,500 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends. F1 · derivative.expiration_date: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 1,227 shares of Common Stock. This issuance is pursuant to the ratable three year vesting schedule of the 3,500 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends. Read SEC document |
| April 16, 2023 Filed Apr 19, 2023 20:30 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-006710 · form4-04192023_040407.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER, SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On April 16, 2023, the Reporting Person had Time-Based Restricted Stock Units (the "TBRSUs") vest in the amount of 1,227 shares of Common Stock. This issuance is pursuant to the ratable three year vesting schedule of the 3,500 TBRSU award that was granted on April 16, 2021 and is adjusted for cash dividends. Read SEC document |
| September 13, 2022 Filed Sep 14, 2022 20:25 UTC | ARGAN INC AGX · Entity 3828 | GrantPerformance-Based Restricted Stock Units · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009611 · form4-09142022_010946.xml · derivative · entry 2 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F3 · derivative.exercise_date: On September 13, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 2,500 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. F3 · derivative.expiration_date: On September 13, 2022, the Reporting Person was granted Performance-Based Restricted Stock Units (the "PBRSUs") in the target number of 2,500 shares (the "Target"), the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies disclosed in the Issuer's 2022 Proxy Statement. Each PBRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the Target, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. Read SEC document |
| September 13, 2022 Filed Sep 14, 2022 20:25 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 12,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009611 · form4-09142022_010946.xml · derivative · entry 1 Deily Richard H · CIK 0001358787 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,334 Underlying: Common Stock · 12,500 shares Expires not disclosed F1 · derivative.exercise_date: On September 13, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 12,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 9/13/2023. F1 · derivative.expiration_date: On September 13, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 12,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 9/13/2023. F2 · balance_after: As of the date of this filing, the total number of TBRSUs beneficially owned by the Reporting Person includes (a) 2,334 shares of TBRSUs granted on April 16, 2021; (b) 3,500 shares of TBRSUs granted on April 18, 2022; and (c) 12,500 shares of TBRSUs granted on September 13, 2022. All are to vest pursuant to their respective three year vesting schedule similar to the one described in footnote 1 above. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 20:15 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 3,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004132 · form4-04192022_040416.xml · derivative · entry 3 Deily Richard H · CIK 0001358787 · VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Underlying: Common Stock · 3,500 shares Expires not disclosed F5 · derivative.exercise_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 3,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023. F5 · derivative.expiration_date: On April 18, 2022, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 3,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/18/2023. F6 · balance_after: As of the date of this filing, the remaining number of TBRSUs beneficially owned by the Reporting Person includes (a) 2,334 shares of TBRSUs granted on April 12, 2021; and (b) 3,500 shares of TBRSUs granted on April 18, 2022, all to vest pursuant to the three year vesting schedule reported under footnote 5 above. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 20:15 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 3,500 | $0.00 Strike: $36.78 | $0.00 |
DisclosureSEC source: 0001415889-22-004132 · form4-04192022_040416.xml · derivative · entry 2 Deily Richard H · CIK 0001358787 · VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,000 Underlying: Common Stock · 3,500 shares Expires 2032-04-18 F2 · shares: On April 18, 2022, the Reporting Person received 10-year options to purchase 3,500 shares of the Issuer's common stock with an exercise price of $36.78 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/18/2023. F3 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029; F4 · balance_after: (e) options to acquire 10,000 shares of common stock at a price of $33.81 per share with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030; (f) options to acquire 3,500 shares of common stock at a price of $54.60 per share with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031, and (g) options to acquire 3,500 shares of common stock at a price of $36.78 per share with a Date Exercisable of 4/18/2023 and Expiration Date of 4/18/2032. Options identified in subjects (c), (d), (e), (f) and (g) are subject to the aforementioned three-year ratably vesting schedule. Read SEC document |
| April 16, 2022 Filed Apr 19, 2022 20:15 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 1,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004132 · form4-04192022_040416.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On April 16, 2022, the Reporting Person had Time-Based Restricted Stock Units (the "TRSUs") vest in the amount of 1,193 shares of Common Stock. This issuance is pursuant to the three year vesting schedule of the 3,500 TRSU award that was granted on April 16, 2022 and is adjusted for cash dividends. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 22:34 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 3,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-052673 · tm2113525-4_4seq1.xml · derivative · entry 3 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 3,500 shares Expires not disclosed F4 · shares: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 3,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022. F4 · derivative.exercise_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 3,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022. F4 · derivative.expiration_date: On April 16, 2021, the Reporting Person was granted Time-Based Restricted Stock Units (the "TBRSUs") covering 3,500 shares of common stock. The TBRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 04/16/2022. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 22:34 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to Purchase Common Stock · Derivative | 3,500 | $0.00 Strike: $54.60 | $0.00 |
DisclosureSEC source: 0001104659-21-052673 · tm2113525-4_4seq1.xml · derivative · entry 2 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,500 Underlying: Common Stock · 3,500 shares Expires 2031-04-16 F1 · shares: On April 16, 2021, the Reporting Person received 10-year options to purchase 3,500 shares of the Issuer's common stock with an exercise price of $54.60 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/16/2022. F2 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029; F3 · balance_after: (e) options to acquire 10,000 shares of common stock at a price of $33.81 per share with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030; and (f) options to acquire 3,500 shares of common stock at a price of $54.60 per share with a Date Exercisable of 4/16/2022 and Expiration Date of 4/16/2031. Options identified in subjects (c), (d), (e) and (f) are subject to the aforementioned three-year ratably vesting schedule. Read SEC document |
| October 02, 2020 Filed Oct 2, 2020 20:15 UTC | ARGAN INC AGX · Entity 3828 | PurchaseCommon Stock | 250 | $42.02 | $10,505.00 |
DisclosureSEC source: 0001104659-20-111700 · a4.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · shares: On October 2, 2020, the Reporting Person purchased 250 shares of the Issuer's common stock on the open market at a price of $42.02 per share. Read SEC document |
| April 16, 2020 Filed Apr 20, 2020 21:05 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $33.81 | $0.00 |
DisclosureSEC source: 0001104659-20-048748 · a4.xml · derivative · entry 2 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 10,000 shares Expires 2030-04-16 F1 · shares: On April 16, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $33.81per share. The options will vest ratably over three years on each anniversary of the grant date starting from 4/16/2021. F2 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029 and; F3 · balance_after: (e) options to acquire 10,000 shares of common stock at a price of $33.81 per share with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030. Options identified in subjects (c), (d) and (e) are subject to the aforementioned three-year ratably vesting schedule. Read SEC document |
| October 21, 2019 Filed Oct 22, 2019 20:28 UTC | ARGAN INC AGX · Entity 3828 | PurchaseCommon Stock | 750 | $39.25 | $29,437.50 |
DisclosureSEC source: 0001104659-19-055557 · a4.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 F1 · balance_after: On October 21, 2019, the Reporting Person purchased 750 shares of the Company's common stock on the open market at a price of $39.25 per share. Read SEC document |
| April 12, 2019 Filed Apr 16, 2019 14:24 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $50.30 | $0.00 |
DisclosureSEC source: 0001104659-19-021519 · a4.xml · derivative · entry 1 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 10,000 shares Expires 2029-04-12 F1 · shares: On April 12, 2019, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $50.30 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/12/2020. F2 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share, subject to a three-year ratably vesting schedule, with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; and (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share, subject to the aforementioned three-year ratably vesting schedule, with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029. Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 00:12 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $37.60 | $0.00 |
DisclosureSEC source: 0001104659-18-024301 · a4.xml · derivative · entry 1 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires 2028-04-13 F1 · shares: On April 13, 2018, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $37.60 per share. The options will vest ratably over three years on each anniversary of the grant date starting from 04/13/2019. F2 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; and (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share, subject to the aforementioned three-year ratably vesting schedule, with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028. Read SEC document |
| April 06, 2017 Filed Apr 7, 2017 21:39 UTC | ARGAN INC AGX · Entity 3828 | GrantStock Option to purchase Common Stock · Derivative | 10,000 | $0.00 Strike: $64.25 | $0.00 |
DisclosureSEC source: 0001104659-17-022313 · a4.xml · derivative · entry 1 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2027-04-06 F1 · shares: On April 6, 2017, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $64.25 per share. F2 · balance_after: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; and (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 12:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,650 | $72.01 | $190,819.88 |
DisclosureSEC source: 0001104659-17-001618 · a4.xml · nonDerivative · entry 2 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · shares: On January 6, 2017, the Reporting Person sold 2,650 shares of the Issuer's common stock on the open market at a price of $72.0075 per share. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 12:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,650 | $16.47 | $43,645.50 |
DisclosureSEC source: 0001104659-17-001618 · a4.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On January 6, 2017, the Reporting Person exercised his stock option received pursuant to an agreement dated April 2, 2012 to purchase 2,650 shares of the Issuer's common stock at a price of $16.47 per share. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:56 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 2,350 | $59.00 | $138,650.47 |
DisclosureSEC source: 0001104659-16-148632 · a4.xml · nonDerivative · entry 2 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · shares: On October 3, 2016, the Reporting Person sold 2,350 shares of the Issuer's common stock on the open market at a price of $59.0002 per share. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:56 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 2,350 | $16.47 | $38,704.50 |
DisclosureSEC source: 0001104659-16-148632 · a4.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On October 3, 2016, the Reporting Person exercised his stock option received pursuant to an agreement dated April 2, 2012 to purchase 2,350 shares of the Issuer's common stock at a price of $16.47 per share. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 20:25 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 10,000 | $52.46 | $524,577.00 |
DisclosureSEC source: 0000899243-16-028963 · doc4.xml · nonDerivative · entry 2 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · shares: On September 9, 2016, the Reporting Person sold 10,000 shares of the Issuer's common stock on the open market at a price of $52.4577 per share. As of the date of this Filing, the Reporting Person does not own any share of common stock of the Issuer other than options to purchase a total of 15,000 shares of common stock. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 20:25 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 10,000 | $27.09 | $270,900.00 |
DisclosureSEC source: 0000899243-16-028963 · doc4.xml · nonDerivative · entry 1 Deily Richard H · CIK 0001358787 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On September 9, 2016, the Reporting Person exercised his stock option received pursuant to an agreement dated April 16, 2014 to purchase 10,000 shares of the Issuer's common stock at a price of $27.09 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.